Feb 02, 2022 / 07:00AM GMT
Presentation
Feb 02, 2022 / 07:00AM GMT
=====================
Corporate Participants
=====================
* Minetake Kitagawa
Astellas Pharma Inc. - Senior VP of Development Project Management
* Naoki Okamura
Astellas Pharma Inc. - Executive VP, CFO, Chief Strategy Officer, Chief Business Officer & Representative Director
* Yukio Matsui
Astellas Pharma Inc. - Chief Commercial Officer & Senior Corporate Executive
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
======
Astellas Pharma Inc
(STU:YPH)
€
11.4
+0.10 (+0.88%)
Market Cap: 20.87 Bil
Enterprise Value: 22.37 Bil
PE Ratio: 13.32
PB Ratio: 2.12
GF Score: 83/100 Q3 2022 Astellas Pharma Inc Earnings Presentation Transcript
Feb 02, 2022 / 07:00AM GMT
Release Date Price:
€14.95
(+4.73%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot